In the past few years, cannabis legalization is growing faster than ever in many parts of the world. This has opened new frontiers for business in many states of the US as well as European countries. It has attracted attracting heavy investments in the field. Although the majority of investments occur in the extraction of cannabis compounds from the plant. It looks like Synthetic Biology has some interesting future ventures in the field too.
One of the companies in this new field is a Danish startup by the name Octarine Bio. The founder Nehtaji Gallage was first acquainted with cannabinoids when she was a researcher at the University of Copenhagen. She was observing specific genes that produce unique properties in the cannabis plant. It was this research that made her realize that synthetic biology has potential in this industry as well.
Obviously, this industry has just started to grow. It is after the wave of legalization that cannabis is considered normal in most parts of the world. This is an issue that Gallage faced in her early years. She said that “When we started Octarine, we first understood the strong stigma around these molecules. Some would consider any scientific research in this field is not ‘real science.”
With more and more research being put into this field the initial stigma with cannabis is declining. Furthermore, numerous researches have highlighted poor management of Neurological and psychological conditions by current drugs. On the other hand, Cannabinoids have some exceptional results in these areas.
Hyacinth Biologicals is also exploring the synthetic cannabinoids realm. The founder of the Montreal-based company Kevin Chen started this company in his pursuit to achieve something with yeast that could be profitable. His interest in the area helped him discover the effects of cannabinoids on epilepsy and chronic pain.
The conventional source of cannabinoids is cannabis plants. However, growing cannabis consumes a lot of precious resources and has some serious environmental problems. According to Chen “While you can grow your plants at home, scaling up is expensive and you have to worry about pests and increased carbon output.” this is the driving factor for most of the companies working in the field of Synthetic Biology.
Microbial Fermentation is a fairly recent alternative to cultivating Cannabis. Earlier in 2019, researchers from UC Berkeley in the US produced THC and CBD artificially in yeast opening doors to a whole new dimension of possibilities. Not only dies this approach reduces Land and Water use it also decreases energy waste as well as costs of using pesticides and fertilizers.
Fermentation is a fairly old technique. It is used by many industries to produce food, beverages, fuels, and various chemicals. If scientists continue to work in this field we can also have microbes produce our desired cannabinoid product. Doing so in plants is fairly difficult, However, on the other hand, once you train a microorganism it is fairly easy.
Now the choice of specific microbe varies from company to company. Some companies are working with bacteria while others are pursuing the help of algae in the field. One critical factor for this industry right now is scalability. Researchers and scientists in the field still need to find a way to make synthetic production both scalable as well as profitable. Doing so is not an easy task and can take years however, it is clear that this is the future direction of this industry as well.
Texas Med Store Starts Selling Cannabis-Infused Gummies As Medical Marijuana
As more and more states legalize cannabis use, dispensaries are finding new ways to morph cannabis into daily-use things. The popularity of medical marijuana is undoubtedly off the charts. In another of such events, one of the state’s dispensaries now offers medical marijuana-infused gummies.
The Lone Star state is the second largest of all the states, falling behind Alaska. The fact that Elon Musk has set up his residence in the state has made it even more popular. Surterra Wellness, a well-known Florida-based marijuana company, is also operating in Texas. with a dispensary in Austin — launched its line of Surterra Wellness is bringing cannabis-infused lineup of edibles to cater to the needs of patients and cannabis consumers alike. This will provide patients with THC in a less intimidating form. The president of Surterra Wellness is positive about the impact this lineup of edibles can have.
Gummy Bears Carrying Marijuana
Mr. Ruark, the Surterra Wellness president, believes that the popularity of gummies makes them ideal to administer medicinal marijuana. Gummies are by far the most popular dosing form in medical markets across the United States. In addition to the popularity of gummies, they also contain terpenes. Terpenes provide a plethora of therapeutic properties and is an all natural extract.
They also give medical marijuana users a new way of ingesting THC. The many flavors that gummy bears are available, make it a great option to use for the deliverance of medical marijuana.
Medicinal marijuana, although legal in Texas, is under extreme regulation and restrictions. Residents must opt into the Texas Compassionate Use Program that allows subscribers to use cannabis products for medicinal purposes. This programme was created in 2015 and is caters to patients of medical conditions such as epilepsy, seizures, terminal cancer, multiple sclerosis, incurable neurological disorders, autism and ALS.
Now, with the advancements in the way marijuana is covering ground, cannabis advocates in Texas are pressuring legislators to expand the program. There are expectations that the expansion will include patients suffering from PTSD.
Ruark believes that people are largely unaware of the medicinal programme in Texas. Also, he believes these gummies will change this. He thinks that his company can raise awareness about the state’s medical marijuana program.
Increasing The Cannabis Family by 2 Million
Increased reach will allow two million patients to use it who qualify for it even now but don’t use it because they don’t know about the program.
The president of the dispensaries wants everyone to benefit from the nature’s gift. He wants everyone to reap the benefits of cannabis. It may be of special benefit for veterans in dealing with PTSD after their return back to a normal life.
These lovely gummy treats come in a bottle that costs $60 and contains 200 milligrams of THC in total.
Cannabis Antibiotics Can Be Solution For Treating Drug-Resistant Diseases
The cannabis plant contains multiple components of varying benefits, of which some constituents are psychoactive while others are non-psychoactive and have other pharmacological impacts. Because of the pharmacological benefits, researchers are working to formulate cannabis antibiotics.
According to the research of The University of Queensland, CBD is a component present in marijuana, is non-psychoactive, and is capable of killing bacteria. It is useable in antibiotics due to its ability to kill bacteria responsible for gonorrhea, meningitis, and legionnaires.
Moreover, according to studies, there is a possibility that drug-resistance diseases can cause more than 10 million deaths per year by 2050. The UN warns that there is an urgent need to deal with drug-resistant illnesses. Furthermore, finding solutions to the problems of drug resistance must be of utmost priority.
Drug resistance is growing, leading to critical problems shortly. According to neurologists, within five years, the NHS will successfully develop effective cannabis-antibiotics. Moreover, the treatment of drug-resistant diseases will be possible with the use of this marijuana containing antibiotics.
Cannabis In Antibiotics
CBD is the cannabidiol, a major non-psychoactive and second-most prevalent component of the active ingredients of marijuana. Two institutions researched using cannabis in antibiotics. The institutions that collaborate for research are the University of Queensland and Botanix Pharmaceuticals Limited.
In their research, researchers examined how the CBD of cannabis penetrates through the protective membranes of multiple bacteria. Moreover, not only does the CBD enter the bacteria, but it also kills them.
Of the bacteria through which CBD penetrates are bacteria for meningitis, legionella, and Neisseria gonorrhea. The legionella bacteria cause legionnaire’s disease characterized by cough, shortness of breath, high fever, muscle pain, nausea, vomiting, and headache.
The researchers found that CBD was able to break down the biofilm of the bacteria. Biofilm is a slimy build-up of bacteria released by it to survive against antibiotic treatment. Moreover, the biofilm’s slimy layer is similar to a dental plaque on the surface.
What Is In The Future For Cannabis?
Cannabis-infused antibiotics may be available in the market. According to Professor Mike Barnes, pretty-soon general practitioners will start prescribing CBD pills to treat infectious diseases. Research on marijuana is progressing fast. Moreover, there are chances of formulating much better cannabis products for medicinal use.
According to Mike Barnes, it is high time that individuals understand the medical benefits of marijuana and take advantage of the plant to its full capacity. Moreover, the marijuana plant is useable in various ways to improve the condition of patients.
The new research led by the University of Queensland and Botanix Pharmaceutical Limited is helpful in the subject. However, further research is vital for developing much better, safer, and effective drugs containing CBD of marijuana.
More Studies Essential For A Better Future
According to Professor Mike Barnes, if CBD is placed next to bacteria in a plate, the cannabidiol will kill the bacteria right away. However, if a tablet containing CBD is on the same plate as the bacteria, the effect of CBD will be slower.
The professor is confident that with further research on the subject, better medicine formulation can occur for treating drug-resistant diseases. Moreover, UK regulators can formulate something that can fight against antibiotic-resistant gonorrhea. Furthermore, the formation of antibiotics for drug-resistant gonorrhea is the utmost priority of the World Health Organization.
Once the formulation of the cannabis-containing antibiotics is complete, the drugs will need the approval to conduct preclinical-trials and clinical trials. After completing the clinical trials and research investigations, the authorities will consider the drugs for approval after which they will be available in the market.
Deep studies and research investigations enable the formulation of a more effective formulation. The quicker the cannabis containing antibiotics gets approval, the sooner they will be in the market for treating drug-resistant bacterial diseases.
International Market For Marijuana-Infused Drinks On The Rise
The international market for marijuana products, especially marijuana-infused alcoholic drinks, is rising. Agreements and contracts or partnerships are being made globally to expand the cannabis industry and facilitate a larger number of clients.
Individuals like to use alcoholic drinks containing marijuana for recreational purposes. Such drinks enable them to have fun, enjoy themselves in their own company and be themselves. Moreover, alcoholic drinks with cannabis enable individuals to get rid of a stressful situation.
Some of the best cannabis-containing drinks include CBD-Enriched Ales, Cherry CBD Cocktails, CBD-Infused Bloody Mary Mixes, and Inaugural Sparkling Cannabis Wines. In addition, individuals can try CBD Cocktail Bitters, CBD-Infused Hemp Rums, Cannabis-Based Beers, Vegan Cannabis Wines, Marijuana-Infused IPAs, CBD-Infused Cocktail Bars and THC-Infused Beers.
Some more weed-containing drinks include Cannabis-Infused Beers, Cannabis Oil-Infused Beers, Adaptogenic Non-toxicating Cocktails, All-Natural Social Tonics, and CBD-infused Green Wines. Some drinks contain marijuana but are non-alcoholic, and others have alcohol in them. However, their selection entirely depends upon individuals’ tastes and choices. But customer choice determines the sale of the product and its market value. Understanding the market and product value is essential to run a successful business.
The Study About Marijuana-Infused Alcoholic Drinks
Research regarding the marijuana-infused alcoholic drink market highlights the latest trends in the industry. However, the study also mentions the breakdown of marijuana products and services. Furthermore, the report elaborates on factors that affect the sales of drinkable cannabis products. It elaborates on the market status, size, share, and growth factors relating to one another.
Moreover, the research gathers data from primary interviews and in-house expert reviews. The study explained the effects of the coronavirus-pandemic on sales, demand, production, and the overall market.
Various companies are conducting the international business of marijuana-infused drinks. Some of the big names are COALITION BREWING (USA), Heineken (Netherlands), Klosterbrauerei WeiAYenohe (Germany), and Rodnik (Russia).
The report on the Marijuana-Infused Alcoholic Drink Market gives an estimation of the increase in the growth rate of drinks. Moreover, it predicts the growth rate for the next 5 to 6 years by analyzing the progress of cannabis-infused alcoholic drinkables in the market.
Furthermore, the research analysis includes monitoring and estimating market size, product/ service demand and production, SWOT of providers, and every minute detail about strategies alterations or developments in the marijuana industry.
Types Of Alcoholic Drinks And Their Selling Method
Multiple marijuana industries provide alcoholic drinks containing marijuana. Alcoholic beverages containing cannabis include cannabis-infused beers, weed-containing spirits, and cannabis-containing wines.
Marijuana-containing alcoholic drinks are sellable online and offline means. The market for alcoholic-drinks containing weed is present in North America, Latin America, Middle East, Asia-Pacific, Africa, and Europe. Sales occur in a clear, concise, and professional manner. The report regarding the market of weed drinks gives details and graphical presentations of facts and figures.
By viewing the report, individuals can understand the market strategy, evolution, and progress. Moreover, details about each type of alcoholic drink containing marijuana are in the analytical-report.
What Can An Individual Know From This Report?
The report contains information regarding every R&D plan and M&A. Moreover, it mentions the collaborations made on a global and national platform. Furthermore, individuals can find collective data about CAGR, gross margin, regional price, revenue, and much more regarding alcoholic drinks containing marijuana.
By studying the research analysis, individuals will be able to understand the scope of the market. Moreover, the report uses various analytical tools for the collection and analysis of data. The analytical tools include Porter’s five-force analysis, feasibility study, SWOT analysis, and ROI analysis.
Furthermore, individuals can learn about the major and minor business owners and their progress. Additionally, information regarding each alcoholic drink containing marijuana is available in the report of the Cannabis-Infused Alcoholic Drinks. Knowing about the potential benefits and risk factors of the cannabis industry, particularly matters of marijuana containing alcoholic drinks, enables individuals to do better in their business.
Cannabis2 years ago
How CBD oil works?
Cannabis2 years ago
Research Suggests Cannabis Effective in Treating Endometriosis
Health1 year ago
Diabetes Freedom Review – A Natural Way To Beat Diabetes Type 2
Cannabis2 years ago
CBD Gummies: How does it work? Benefits, Pricing and Packages
Featured2 years ago
Prosper Wellness TurmeriCBD Review – A combination of Turmeric and CBD?
Cannabis2 years ago
What are the main advantages of consuming CBD oil?
Health1 year ago
VitaMove, a Popular Formula to Relieve Back Pain is Restocked
Cannabis1 year ago
Can Cannabis Survive in Pharma?